Pathological myopia
Conditions
Interventions
Sponsors
Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
4 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Prevent and treat pathological myopia and its associated complications using the method of integrative medicine Inclusion criteria of pathological myopia (1)Signed informed consent; (2)At least one eye meets the criteria of diagnosis for pathological myopia:spherical equivalent <-6.00D,visual acuity or visual field abnormalities, and maculopathy of fundus including: macular atrophy, macular hemorrhage, peridisc atrophy and other fundus changes. 2. Prevent and control pathological myopia using the method of integrative medicine Inclusion criteria of potential pathological myopia with high risk: (1) Signed informed consent; (2) -6.00D < Spherical Equivalent after ciliary paralysis <= -1.00D for at least one eye; (3) <= 16 years oldmale or female; (4) Without pathological myopia-related maculopathy of fundus; (5) Without any other organic lesions affecting vision for both eyes; (6) With constitution of yang deficiency, qi deficiency, yin deficiency or other biased susceptible constitution for pathological myopia, or with parameters for high risk for pathological myopia..
Exclusion criteria
Exclusion criteria: 1. Prevent and treat pathological myopia and its associated complications using the method of integrative medicine Exclusion criteria of pathological myopia: (1)Exclude patients with systemic diseases caused other systemic impacts including eye impacts, such as hypertensive retinopathy, diabetic retinopathy and so on; (2)With moderate or severe liver dysfunction, or patients with severe cardiac, pulmonary or renal dysfunction, hematopoietic system diseases and mental illness; (3)Those who cannot cooperate with the investigation. 2. Prevent and control pathological myopia using the method of integrative medicine Exclusion criteria of potential pathological myopia with high risk: (1)Exclude patients with long-term application for therapy of traditional Chinese medicine (including traditional Chinese medicine, acupuncture, electroacupuncture, massage, moxibustion, pressing beans at auricular points and so on), or low concentration atropine eye drops, or visual training and other related treatment; (2)Exclude patients with serious systemic diseases, including cardio-cerebrovascular, liver, kidney, hematopoietic system and mental illness; (3)Exclude patients with mental diseases; (4)Exclude patients participating in other clinical trials; (5)Exclude patients with high risk for failure to accomplish the experiment or lead to complicate enrollment according to the judgment of the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Uncorrected eyesight;Diopter;Axial length;Optical Coherence Tomography Angiography;Regulatory function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Corrected eyesight;Intraocular pressure;Corneal curvature;SLO;Visual field;Electrophysiology;Fundus fluorescein angiography;Improvement of asthenopia and systemic symptoms;Contrast sensitivity;Opd;TCM Constitutions;TCM syndrome differentiation;Blood cell analysis;Liver function;Kidney function;Routine urine examination; | — |
Countries
China
Contacts
Public ContactBi Hongsheng
Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine
Outcome results
None listed